IMUC — Eom Pharmaceutical Holdings Income Statement
0.000.00%
Last trade - 00:00HealthcareHighly SpeculativeMicro Cap
- $20.39m
- $22.23m
Annual income statement for Eom Pharmaceutical Holdings, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2015 December 31st | 2016 December 31st | 2017 December 31st | 2020 December 31st | 2021 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | 10-K | 10-K | 10-K | PROSPECTUS/A | PROSPECTUS/A |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Revenue | |||||
| Total Revenue | 0 | 0 | 0 | 0 | 0 |
| Selling / General / Administrative Expenses | |||||
| Research And Development | |||||
| Unusual Expense / Income | |||||
| Total Operating Expenses | 15.5 | 24.1 | 13.4 | 1.45 | 5.14 |
| Operating Profit | -15.5 | -24.1 | -13.4 | -1.45 | -5.14 |
| Total Net Non Operating Interest Income / Expense | |||||
| Net Income Before Taxes | -12.8 | -22.1 | -14.3 | -1.45 | -5.15 |
| Provision for Income Taxes | |||||
| Net Income After Taxes | -12.8 | -22.1 | -14.3 | -1.45 | -5.15 |
| Net Income Before Extraordinary Items | |||||
| Extraordinary Items | |||||
| Net Income | -12.8 | -22.1 | -14.3 | -1.45 | -5.15 |
| Adjustments to Net Income | |||||
| Income Available to Common Shareholders Excluding Extraordinary Items | |||||
| Income Available to Common Shareholders Including Extraordinary Items | |||||
| Diluted Net Income | -12.8 | -22.1 | -17.7 | -1.45 | -5.15 |
| Diluted Weighted Average Shares | |||||
| Basic EPS Including Extraordinary Items | |||||
| Diluted EPS Including Extraordinary Items | |||||
| Diluted EPS Excluding Extraordinary Items | |||||
| Normalised Income Before Taxes | |||||
| Normalised Income After Taxes | |||||
| Normalised Income Available to Common Shareholders | |||||
| Diluted Normalised EPS | -58.7 | -78.9 | -17.6 | -0.013 | -0.023 |
| Dividends per Share |